Incidence of clinically relevant psychiatric symptoms during glioblastoma treatment: an exploratory study.

ABSTRACT:

Purpose

In addition to neurological symptoms glioblastoma (GBM) patients can experience psychiatric complaints, which are often hard to recognize and difficult to treat. Research on psychiatric symptoms during glioblastoma treatment is limited, but can have significant impact on quality of life, treatment processes and even survival. The aim of this study is to explore the incidence of clinically relevant psychiatric symptoms, during glioblastoma treatment and active surveillance.

Methods

Medical records of 302 GBM patients were reviewed from diagnostic surgery until discontinuation of treatment or active surveillance. Clinical relevance was defined as psychiatric symptoms that interfered with the oncological treatment and required referral to a psychiatrist. "Referred" vers

SUBMITTER: Regli LKP 

PROVIDER: S-EPMC10232638 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature